Loading organizations...
Loading organizations...
Therapeutics company
R1 Therapeutics has raised $78.0M across 1 funding round.
R1 Therapeutics has raised $78.0M in total across 1 funding round.
R1 Therapeutics has raised $78.0M in total across 1 funding round.
R1 Therapeutics's investors include Abingworth, F-Prime Capital, Andrew Sinclair, Chong Xu, DaVita Venture Group, Ben Auspitz, SymBiosis, U.S. Renal Care.
R1 Therapeutics has raised $78.0M across 1 funding round.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| $78.0M R1 Therapeutics Series A | Abingworth, F-Prime Capital, Andrew Sinclair, Chong Xu, DaVita Venture Group, Chong Xu | Ben Auspitz, SymBiosis, U.S. Renal Care |